NK NK

@Kenny Shenbarger

According to the companies:

"Following the closing of the transaction, the combined company will assume the ImmunityBio name and continue to be listed on the NASDAQ exchange. However, the combined company ticker symbol is expected to be changed to IBRX."

The "slides" seem to be the Investor Presentation pdf. Link is right under the webcast registration link on ImmunityBio.com events page

..........eh?

NK is the long run vaccine which is the one that is going to get approved in the end. Pfizer does not come close to obtaining the durability of the vaccine NK is making. They (NK) are taking their time, the smart move. Need to get it right. Make a call on Pfizer for now but I don’t think it’s gonna be the one that can handle the volume of vaccines in which the whole world will eventually need. It will not only be Pfizer making the vaccines. Coming off a global pandemic.
Hold strong ?

Nice entry

@ Russ
LOL
?

i'm wondering, are NK cancer trials still proceeding during the epidemic?

@ Dan Knaupp
They just had & closed one this week. Raised about $90 million, I believe.

NK does not break today’s gaping. The lowest point is on 3:00pm today (edge of the gap). We should see continue rallying tomorrow to pass above $13.00 ( highly possible), if index continuously move up.

@ Sterling Archer

I've looked hard and I can't find any new news driving this today. So, what is it & where can I read it?